These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29145933)

  • 1. Quantitative Structure - Pharmacokinetics Relationships for Plasma Protein Binding of Basic Drugs.
    Zhivkova ZD
    J Pharm Pharm Sci; 2017; 20(1):349-359. PubMed ID: 29145933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Structure - Pharmacokinetic Relationships for Plasma Clearance of Basic Drugs with Consideration of the Major Elimination Pathway.
    Zhivkova ZD
    J Pharm Pharm Sci; 2017; 20(0):135-147. PubMed ID: 28554345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative structure--plasma protein binding relationships of acidic drugs.
    Zhivkova Z; Doytchinova I
    J Pharm Sci; 2012 Dec; 101(12):4627-41. PubMed ID: 22961754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Structure - Pharmacokinetics Relationships Analysis of Basic Drugs: Volume of Distribution.
    Zhivkova ZD; Mandova T; Doytchinova I
    J Pharm Pharm Sci; 2015; 18(3):515-27. PubMed ID: 26517139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of steady-state volume of distribution of acidic drugs by quantitative structure-pharmacokinetics relationships.
    Zhivkova Z; Doytchinova I
    J Pharm Sci; 2012 Mar; 101(3):1253-66. PubMed ID: 22170307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSPR models for the prediction of apparent volume of distribution.
    Ghafourian T; Barzegar-Jalali M; Dastmalchi S; Khavari-Khorasani T; Hakimiha N; Nokhodchi A
    Int J Pharm; 2006 Aug; 319(1-2):82-97. PubMed ID: 16698204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative structure-pharmacokinetic relationship modelling: apparent volume of distribution.
    Ghafourian T; Barzegar-Jalali M; Hakimiha N; Cronin MT
    J Pharm Pharmacol; 2004 Mar; 56(3):339-50. PubMed ID: 15025859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of pseudo-equilibrium constant affords improved QSAR models of human plasma protein binding.
    Zhu XW; Sedykh A; Zhu H; Liu SS; Tropsha A
    Pharm Res; 2013 Jul; 30(7):1790-8. PubMed ID: 23568522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial least square and hierarchical clustering in ADMET modeling: prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands.
    Nikolic K; Filipic S; Smoliński A; Kaliszan R; Agbaba D
    J Pharm Pharm Sci; 2013; 16(4):622-47. PubMed ID: 24210068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting binding affinities of diverse pharmaceutical chemicals to human serum plasma proteins using QSPR modelling approaches.
    Basant N; Gupta S; Singh KP
    SAR QSAR Environ Res; 2016; 27(1):67-85. PubMed ID: 26854728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Prediction of Compounds Binding to Human Plasma Proteins by QSAR Models.
    Sun L; Yang H; Li J; Wang T; Li W; Liu G; Tang Y
    ChemMedChem; 2018 Mar; 13(6):572-581. PubMed ID: 29057587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review.
    Lambrinidis G; Vallianatou T; Tsantili-Kakoulidou A
    Adv Drug Deliv Rev; 2015 Jun; 86():27-45. PubMed ID: 25819487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.
    Ye M; Nagar S; Korzekwa K
    Biopharm Drug Dispos; 2016 Apr; 37(3):123-41. PubMed ID: 26531057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma protein binding affinity and its relationship to molecular structure: an in-silico analysis.
    Gleeson MP
    J Med Chem; 2007 Jan; 50(1):101-12. PubMed ID: 17201414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of vitreal half-life based on drug physicochemical properties: quantitative structure-pharmacokinetic relationships (QSPKR).
    Durairaj C; Shah JC; Senapati S; Kompella UB
    Pharm Res; 2009 May; 26(5):1236-60. PubMed ID: 18841448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Distribution Part 2. Predicting Volume of Distribution from Plasma Protein Binding and Membrane Partitioning.
    Korzekwa K; Nagar S
    Pharm Res; 2017 Mar; 34(3):544-551. PubMed ID: 27966088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Informing the Human Plasma Protein Binding of Environmental Chemicals by Machine Learning in the Pharmaceutical Space: Applicability Domain and Limits of Predictability.
    Ingle BL; Veber BC; Nichols JW; Tornero-Velez R
    J Chem Inf Model; 2016 Nov; 56(11):2243-2252. PubMed ID: 27684444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational prediction of plasma protein binding of cyclic peptides from small molecule experimental data using sparse modeling techniques.
    Tajimi T; Wakui N; Yanagisawa K; Yoshikawa Y; Ohue M; Akiyama Y
    BMC Bioinformatics; 2018 Dec; 19(Suppl 19):527. PubMed ID: 30598072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
    Lombardo F; Obach RS; Shalaeva MY; Gao F
    J Med Chem; 2002 Jun; 45(13):2867-76. PubMed ID: 12061889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSAR modeling of human serum protein binding with several modeling techniques utilizing structure-information representation.
    Votano JR; Parham M; Hall LM; Hall LH; Kier LB; Oloff S; Tropsha A
    J Med Chem; 2006 Nov; 49(24):7169-81. PubMed ID: 17125269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.